Net Worth Advisory Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
NI
WN
YIH
GWMR
SWM
FFA
TWD
Net Worth Advisory Group's HCAT Position: Q2 2026 in Review
Net Worth Advisory Group sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 36,372 shares — an estimated $46.2K sold.
Net Worth Advisory Group first reported a position in HCAT in Q2 2025 and held it in 3 quarters. The position peaked at $138K in Q2 2025. 8 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Net Worth Advisory Group reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
- Net Worth Advisory Group sold 36,372 Health Catalyst shares in Q2 2026, an estimated $46.2K.
- Net Worth Advisory Group first reported a position in Health Catalyst in Q2 2025 and held it in 3 quarters.
- Net Worth Advisory Group's Health Catalyst position peaked at $138K in Q2 2025.
- 8 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.